Cognitive Enhancement Therapy for Alzheimer’s Disease

@article{Parnetti2012CognitiveET,
  title={Cognitive Enhancement Therapy for Alzheimer’s Disease},
  author={L. Parnetti and U. Senin and P. Mecocci},
  journal={Drugs},
  year={2012},
  volume={53},
  pages={752-768}
}
  • L. Parnetti, U. Senin, P. Mecocci
  • Published 2012
  • Medicine
  • Drugs
  • SummaryAlthough at present there is no definitive treatment or cure for Alzheimer’s disease, different pharmacological strategies are being actively investigated. At present, cholinergic therapy and nootropics and some neuronotrophic agents represent the available approaches to symptomatic treatment of Alzheimer’s disease. The use of cholinesterase inhibitors (ChEI) constitutes the best cholinergic approach to increase acetylcholine levels. Available data suggest that about 15 to 40% of… CONTINUE READING
    15 Citations
    General and domain-specific neurocognitive impairments in deficit and non-deficit schizophrenia
    • 25
    Cognitive Enhancement Therapy for Adults with Autism Spectrum Disorder: Results of an 18-month Feasibility Study
    • 61
    • PDF
    Synthesis and pharmacological evaluation of some new naphthol derived aryloxy derivatives as cognition enhancers
    • 5
    Antiamnesic Activity of Extracts and Fraction of Desmodium Gangeticum
    • 4
    • PDF

    References

    SHOWING 1-10 OF 139 REFERENCES
    Treatment of Alzheimer's disease: future directions
    • 12
    Alzheimer's disease and related disorders.
    • 99
    Idebenone in senile dementia of Alzheimer type: a multicentre study.
    • 57
    Treatment of Alzheimer's disease with cholinergic drugs.
    • V. Kumar, M. Calache
    • Medicine
    • International journal of clinical pharmacology, therapy, and toxicology
    • 1991
    • 43
    Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
    • 298